SMOFKABIVEN émuls perf 1477ml sach 4 pce
7680606890040
CH-60689
B05BA10
07.01.2.
1 / 3
google
Details
- Product number
- 6068902
- CPT
- -
- Packaging group
- 4 x 1477
- Unit
- ml
- Composition
- I) Glucoselösung 42 %: glucosum 187 g ut glucosum monohydricum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 446 ml. II) Aminosäurenlösung mit Elektrolyten: alaninum 10.5 g, argininum 9 g, glycinum 8.2 g, histidinum 2.2 g, isoleucinum 3.8 g, leucinum 5.6 g, lysinum anhydricum 5 g ut lysini acetas, methioninum 3.2 g, phenylalaninum 3.8 g, prolinum 8.4 g, serinum 4.9 g, taurinum 750 mg, threoninum 3.3 g, tryptophanum 1.5 g, tyrosinum 300 mg, valinum 4.6 g, calcii chloridum anhydricum 420 mg ut calcii chloridum dihydricum, natrii glycerophosphas 3.1 g, magnesii sulfas anhydricus 900 mg ut magnesii sulfas heptahydricus, kalii chloridum 3.4 g, natrii acetas 2.6 g ut natrii acetas trihydricus, zinci sulfas anhydricus 9.7 mg ut zinci sulfas heptahydricus, acidum aceticum glaciale, aqua ad iniectabile q.s. ad solutionem pro 750 ml. III) Fettemulsion: sojae oleum raffinatum 16.9 g, triglycerida media 16.9 g, olivae oleum raffinatum 14.1 g, piscis oleum 8.4 g, int-rac-alpha-tocopherolum, phospholipida ex ovo purificata, glycerolum, natrii oleas, natrii hydroxidum, aqua ad iniectabile q.s. ad emulsionem pro 281 ml. . I) et II) et III) corresp.: aminoacida 75 g, nitrogenia 12 g, carbohydrata 187 g, materia crassa 56 g, natrium 60 mmol, kalium 45 mmol, magnesium 7.5 mmol, calcium 3.8 mmol, phosphas 19 mmol, zincum 0.06 mmol, sulfas 7.5 mmol, chloridum 52 mmol, acetas 157 mmol, in emulsione recenter mixta 1477 ml. Corresp. 6700 kJ pro 1477 ml.
Articles (1)
SmofKabiven, Infusionsemulsion 1477 ml
Infusionsemulsion
4 x 1477
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
II
|
10.5 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
75.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
16.9 G | Substance | Wirkstoff (Principe actif) |
|
I
|
187.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
12.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
16.9 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | WIZUS |
|
II
|
9.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
187.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
14.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
8.2 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
III
|
8.4 G | Substance | Wirkstoff (Principe actif) |
|
I
|
- | Substance | HNIDK |
|
II
|
2.2 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
56.0 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
3.8 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
60.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
123C
|
45.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
5.6 G | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
5.0 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
7.5 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
123C
|
3.8 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
123C
|
19.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
3.2 G | Substance | Wirkstoff (Principe actif) |
|
II
|
3.8 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
0.06 MMOL | Substance | Wirkstoff (Principe actif) |
|
III
|
- | Substance | HNIDK |
|
II
|
8.4 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
7.5 MMOL | Substance | Wirkstoff (Principe actif) |
|
123C
|
52.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
4.9 G | Substance | Wirkstoff (Principe actif) |
|
123C
|
157.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
II
|
750.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
3.3 G | Substance | Wirkstoff (Principe actif) |
|
II
|
1.5 G | Substance | Wirkstoff (Principe actif) |
|
II
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
4.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
420.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
3.1 G | Substance | Wirkstoff (Principe actif) |
|
II
|
900.0 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
3.4 G | Substance | Wirkstoff (Principe actif) |
|
II
|
2.6 G | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
9.7 MG | Substance | Wirkstoff (Principe actif) |
|
II
|
- | Substance | WIZUS |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
Authorization holder
Fresenius Kabi (Schweiz) AG
6010 Kriens
Authorization information
- Swissmedic authorization number
- 60689
- Drug name
- SmofKabiven, Infusionsemulsion
- Galenic form
- EMUI
- ATC Code
- B05BA10
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/01/2011
- Authorization expiration date
- 31/12/9999
- IT number
- 07.01.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SMOFKABIVEN émuls perf 1477ml sach 4 pce
- Description (DE)
- SMOFKABIVEN Inf Emuls 1477ml Btl 4 Stk
- Market launch
- 26/01/2011
- Narcotic (BTM)
- No